Prime Medicine (PRME)

• Market cap: $775M
• 1 day: -4.19%
• 5 days: -20.91%
• 1 month: -21.48%
• 3 months: 10.97%
• 6 months: 151.45%
• Year to date: 45.48%
• 1 year: 6.88%
• 5 years: -71.7%
• 10 years: -71.7%
• Sector: Healthcare
• Industry: Biotechnology

About: Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Employees: 214